The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

T••••••• H••••• C••• P••••••• I••

Pharmaceuticalsgroup grade Aon a schedule nowsponsor not established · possible relationship
Also written as: Undrawn Commitment

Nothing material in the last 200 days. No dated change on record yet.

Mark path, consensus per quarter end
Q2 2025: 100¢Q3 2025: 99¢Q4 2025: 98¢Q1 2026: 98¢Q2 2026: 99¢100¢ · 99¢ · 98¢ · 98¢ · 99¢Q2 2025 to Q2 2026
Where each lender marks it, 0 points apart
99¢Consensus: 99¢M••••• A••••• I••••••••• P•••••• L••••••: 99¢M••••• F•••••••• I••••••••• C•••: 99¢99¢
Principal held
at least $18.8M
sum of BDC pieces, a lower bound
Fair value
$18.3M
99c on cost, debt pieces
Unfunded
$46,000
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
2
1 equity pieces beside them
Next maturity
Aug 6, 2031
no dated debt inside 24 months
On the tape since
Mar 31, 2025
latest Jun 30, 2026
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
Every BDC piece · 8 positions across 2 lenderslargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
M••••• A••••• I••••••••• P•••••• L••••••term loan first lien
Investment T••• F•••• L••• S•••••• D••• - T••• L••• S+525, 1.00% F•••• M••••••• D••• 08/06
$9.8M$9.5M
99c
SOFR+525 bp
M••••• F•••••••• I••••••••• C•••term loan first lien
F•••• L••• S•••••• D••• - T••• L••• S•••+525, 1.00% F•••• M••••••• D••• 08/06/31
$8.0M$7.8M
99c
SOFR+525 bp
M••••• F•••••••• I••••••••• C•••revolver first lien
F•••• L••• S•••••• D••• - R••••••• S•••+525, 1.00% F•••• M••••••• D••• 08/06/31
$1.0M$980,000
99c
SOFR+525 bp
M••••• A••••• I••••••••• P•••••• L••••••revolver first lien
Investment T••• F•••• L••• S•••••• D••• - R••••••• S+525, 1.00% F•••• M••••••• D••• 08/06/
$54,000$52,000
98c
SOFR+525 bp
M••••• A••••• I••••••••• P•••••• L••••••unstated lien unstatedNot disclosedNot disclosed
View all 8 positionslargest principal first
BDCInstrumentPrincipalFair valueRate
M••••• A••••• I••••••••• P•••••• L••••••revolver first lien
Investment T••• F•••• L••• S•••••• D••• - R••••••• C••••+525, 1.00% F•••• M••••••• D••• 08
Not disclosed-$1,000//mmaipl.com/20260630#Canadian Overnight Repo Rate Average CORRA+525 bp
M••••• A••••• I••••••••• P•••••• L••••••unstated lien unstatedNot disclosedNot disclosed
M••••• F•••••••• I••••••••• C•••revolver first lien
F•••• L••• S•••••• D••• - R••••••• C••••+525, 1.00% F•••• M••••••• D••• 08/06/31
Not disclosed-$15,000//www.midcapfinancialic.com/20260630#Canadian Overnight Repo Rate Average CORRA+525 bp
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $17.8M99cSOFR+525 bpAug 6, 20312
first lien revolver first lienat least $1.1M99c//mmaipl.com/20260630#Canadian Overnight Repo Rate Average CORRA+525 bpAug 6, 20312
Equity pieces beside the debt: other (Not disclosed fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20262$18.8M$18.3M99c0
Mar 31, 20262$18.9M$18.2M98c0
Dec 31, 20252$18.9M$18.3M98c0
Sep 30, 20252$19.8M$19.0M99c0
All 6 quarters
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20251$9.6M$9.2M100c0
Mar 31, 20252$9.0M$8.8M102c0
What changed
Every change including routine ones
Identity
Group key
T••••••• H••••• C••• P•••••••derivedthe codename stem after legal suffixes and deal words
Spellings
1 across 2 BDCsderived
Industry
Pharmaceuticalsreportedas one filer wrote it